Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13, 117-127
- https://doi.org/10.1016/0192-0561(91)90133-r
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cytotoxic T lymphocytes against HIVAIDS, 1990
- Immune response and epitope mapping of a candidate hiv‐1 p17 vaccine hgp30Journal of Clinical Laboratory Analysis, 1990
- A Formalin-Inactivated Whole SIV Vaccine Confers Protection in MacaquesScience, 1989
- HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptidesNature, 1988
- A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDSNature, 1988
- The immunology of new generation vaccinesImmunology Today, 1987
- Patterns of Antibodies to Human Immunodeficiency Virus Proteins in Different Subclasses of IgGThe Journal of Infectious Diseases, 1987
- AIDS vaccine predictionsNature, 1987
- Impaired Specific Cellular Response to HTLV-III before Other Immune Defects in Patients with HTLV-III InfectionNew England Journal of Medicine, 1986
- In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements.The Journal of Experimental Medicine, 1981